HomeALLO • NASDAQ
add
Allogene Therapeutics Inc
Previous close
$2.40
Day range
$2.35 - $2.54
Year range
$0.86 - $2.80
Market cap
594.82M USD
Avg Volume
5.66M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.77M | -11.25% |
Net income | -38.81M | 35.25% |
Net profit margin | — | — |
Earnings per share | -0.17 | 39.29% |
EBITDA | -39.35M | 31.28% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 250.21M | -14.45% |
Total assets | 415.90M | -24.20% |
Total liabilities | 123.36M | -2.50% |
Total equity | — | — |
Shares outstanding | 243.78M | — |
Price to book | 1.88 | — |
Return on assets | -24.78% | — |
Return on capital | -27.31% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -38.81M | 35.25% |
Cash from operations | -27.60M | 24.79% |
Cash from investing | 33.61M | -38.81% |
Cash from financing | 7.86M | 36.84% |
Net change in cash | 13.87M | -42.15% |
Free cash flow | -14.04M | 18.51% |
About
Founded
2017
Headquarters
Website
Employees
150
